Skip to main content

News

Back
September 11, 2024

TVM Capital Life Science to Participate in LSI Europe ’24 Emerging Medtech Summit 2024

TVM and Portfolio Companies Showcase Transformative Partnerships and Industry Trends in Panel discussions and Presentations Munich, Germany and Montreal, Quebec, Canada (September 11, 2024) – T…
September 9, 2024

CSA Medical Raises $53 Million in Series D Financing to Support PMA of the RejuvenAir System

September 4, 2024

Access Vascular Announces Strategic Partnership with Capstone Health Alliance

August 6, 2024

Leon-Nanodrugs Secures Funds in a Series D Financing

July 24, 2024

Access Vascular Prepares Catheter Location Technology for FDA Submission

April 30, 2024

Kent Imaging Announces FDA Clearance of SnapshotNIR KD205

April 22, 2024

TVM Capital Life Science Leads €23 Million Series C Financing Round for Medical Reporting Technology Pioneer, Smart Reporting

Munich, Germany and Montreal, Quebec, Canada, April 22, 2024 – TVM Capital Life Science (“TVM”), a leading international venture capital firm focused on investments in life sciences innovation, t…
April 2, 2024

Kent Imaging and WoundCentrics Propel Wound Care Forward with New Partnership

March 13, 2024

TVM Capital Life Science to Participate in LSI USA ’24 Emerging MedTech Summit 2024

TVM and Portfolio Companies Showcase Transformative Partnerships and Industry Trends in Panel discussions and Presentations Munich, Germany and Montreal, Quebec, Canada (March 13, 2024) – TVM C…
February 6, 2024

TVM Capital Life Science Co-Leads $16 Million Series A Financing Round for Vektor Medical to Revolutionize Arrhythmia Care

Munich, Germany and Montreal, Quebec, Canada, February 6, 2024 – TVM Capital Life Science (“TVM”), a leading international venture capital firm focused on investments in life sciences innovation,…
January 31, 2024

TVM Capital Life Science Announces €8 Million Investment in myo to Revolutionize Elderly Care via Innovative, Easy-to-Use App

Munich, Germany and Montreal, Quebec, Canada (January 31, 2024) – TVM Capital Life Science (“TVM”), a leading transatlantic venture capital firm focused on investments in life sciences innovation…
July 20, 2023

Tillotts Pharma and TVM Capital Life Science Announce Formation of Mage Biologics to Develop Innovative Oral Antibody Therapy for Ulcerative Colitis

Mage Biologics to develop a monoclonal antibody targeting ulcerative colitis Novel antibody specifically designed for oral administration utilizes Tillotts Pharma’s sustained release appro…
March 17, 2023

TVM Capital Life Science to participate in LSI USA ’23 Emerging Medtech Summit 2023

Company highlights key investments from its commercial-stage medtech portfolio Montreal, Canada / Munich, Germany – 17 March 2023 – TVM Capital Life Science (“TVM”), a leading internationa…
February 23, 2023

TVM Capital Life Science Announces Promotions to Recognize Significant Contributions of Up-and-Coming Leaders

Montreal, Canada / Munich, Germany – 23 February 2023 – TVM Capital Life Science (“TVM”), a leading international venture capital firm focused on investments in life sciences innovation, today an…
February 21, 2023

Esperas Pharma, Inc. Announces Investment from TVM Life Science Innovation I and The Fonds de solidarité FTQ

Montréal, Québec, February 21, 2023 – Esperas Pharma, Inc. (“Esperas”), a company based in Montréal, Québec, today announced a follow-on investment by TVM Capital Life Science (“TVM”) through its…
February 1, 2023

TVM Capital Life Science announces up to USD 24 million investment in oncology company, Recurv Pharma, Inc.

Recurv is the 8th early-stage or product focused company (PFC) investment for TVM Life Science Innovation II Fund Recurv is developing novel taxane, RP-001, against solid tumors RP-…
July 28, 2022

Panthera D-SAD Classic oral appliance now eligible for Medicare reimbursement

Panthera has received notification from the Pricing, Data Analysis and Coding (PDAC) contractor, following their request for a coding decision for the Panthera      D-SAD Classic oral appliance. …
June 21, 2022

Kent Imaging Recognized as Most Innovative Medical Imaging Technology Developer in Canada

SnapshotNIR is enabling clinicians to drive better outcomes in wound care, limb preservation, and surgery, with its diagnostic-driven imaging technology. NEWS PROVIDED BY Kent Imaging Inc….
March 3, 2022

Egg Medical, Inc., Closes on $13 million Financing

Egg Medical, Inc., Closes on $13 million Financing Arden Hills, MN (March 3rd, 2022) — Egg Medical, Inc., a medical device company commercializing technologies to reduce scatter radiat…
February 8, 2022

CENTOGENE Announces CFO Transition and Appointment of Miguel Coego Rios as EVP Finance & Legal and Interim CFO

CAMBRIDGE, Mass. and ROSTOCK, Germany, and BERLIN, February 08, 2022 (GLOBE NEWSWIRE – Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused on generating data-driven insights t…
February 1, 2022

CENTOGENE Announces Nomination of Andreas Busch to Supervisory Board

Nomination adds significant expertise to support pharma partnerships and an impressive track record in value creation CAMBRIDGE, Mass. and ROSTOCK, Germany, and BERLIN, February 1, 2022 (…
February 1, 2022

CENTOGENE Announces USD 62 Million Aggregate Equity and Debt Financings to Support Growth Plan

Enables refocusing on core business of delivering valuable, data-driven insights to patients, and pharmaceutical companies globally EUR 15 million private placement from leading growth inve…
February 1, 2022

CENTOGENE Announces Nomination of Kim Stratton as Chief Executive Officer

Dr. Andrin Oswald resigns as CEO due to prolonged medical leave; Kim Stratton elected as successor CAMBRIDGE, Mass. and ROSTOCK, Germany, and BERLIN, February 1, 2022 (GLOBE NEWSWIRE – Cen…
January 13, 2022

Syndivia and TVM Capital Life Science Announce Creation of Auricula Biosciences to Develop Innovative Therapy for Patients with K-Ras mutant malignancies

Luxembourg, January 13th, 2022 – TVM Life Science Innovation II SCSp announced the Fund’s investment establishing Auricula Biosciences, Inc., a company based in Wilmington, Delaware, USA. …
January 12, 2022

TVM Capital Life Science promotes Dr. Sascha Berger and Dr. Alain Thibault to General Partner

Munich, Germany / Montreal, Canada – 12 January 2022 – TVM Life Science (“TVM”), a leading International Life Sciences Venture Capital firm, today announces the formal promotion of Dr. Sascha Ber…
November 19, 2021

Acer Therapeutics Reports Q3 2021 Financial Results and Provides Corporate Update

NEWTON, MA – Nov. 19, 2021 – Acer Therapeutics Inc. (Nasdaq: ACER), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious rare and life-thr…
November 15, 2021

Nekonal and TVM Capital Life Science Announce Creation of T7 Therapeutics to Develop Innovative Therapy for Patients with Auto-immune diseases

Luxembourg, November 15th, 2021 – TVM Life Science Innovation II SCSp announced the Fund’s investment establishing T7 Therapeutics, Inc., a company based in Wilmington, Delaware, USA. T7 T…
October 7, 2021

Acer Therapeutics Receives Notice of Allowance of Key U.S. Patent Application Covering ACER-001 Formulation

Notice of allowance of ACER-001 formulation composition of matter patent application strengthens proprietary position in U.S. until 2036 NEWTON, MA and GENEVA, SWITZERLAND – October 7, 2021 – Acer…
October 6, 2021

CENTOGENE and Twist Bioscience to Develop Advanced Sequencing Tools to Make Genetic Testing Rapidly Accessible for More Patients With Rare Diseases

Combining Expertise to Advance Precision Medicine, While Enabling a More Efficient and Timely Diagnosis of Rare Diseases Around the World CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN and…
July 14, 2021

Rapid Micro Biosystems Announces Pricing of Initial Public Offering

Source: Rapid Micro Biosystems, Inc. July 14, 2021 21:30 ET LOWELL, Mass., July 14, 2021 (GLOBE NEWSWIRE) — Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (“RapidMicro”), an innovative life sciences …
May 25, 2021

Acer Therapeutics Plans NDA Submission for ACER-001 in Q3 2021
Following Pre-NDA Meeting with FDA

NEWTON, MA and GENEVA, SWITZERLAND – May 25, 2021 – Acer Therapeutics Inc. (Nasdaq: ACER)(“Acer”), a pharmaceutical company focused on the acquisition, development and commercialization of therapie…
March 22, 2021

Relief and Acer Therapeutics Sign Collaboration and License Agreement for Worldwide Development and Commercialization of ACER-001 for the Treatment of Urea Cycle Disorders and Maple Syrup Urine Disease

Relief to potentially pay Acer up to $36 million and royalties in exchange for net profit share and territory rights ACER-001 pre-NDA meeting with U.S. FDA scheduled in Q2 2021 GENEVA, SWITZERLAND …
March 4, 2021

Access Vascular, Inc. Secures $20 Million in Series B Financing

Bedford, MA – 03 March, 2021- Access Vascular, Inc., a company addressing the most common and costly venous access complications, today announced it has closed on a Series B round of finan…
February 1, 2021

TVM Life Science Innovation II SCSp Announces Investment in Vespina Lifesciences Inc.

Luxembourg, February 1st, 2021 – TVM Life Science Innovation II SCSp today announced the Fund’s investment establishing Vespina Lifesciences Inc., a company based in Newark, Delaware. Vesp…
February 1, 2021

TVM Life Science Innovation II SCSp Announces Investment in Sarkana Pharma, Inc.

Luxembourg, February 1st, 2021 –TVM Life Science Innovation II SCSp today announced the fund’s investment establishing Sarkana Pharma, Inc., a company based in Wilmington, Delaware. Sarkan…
January 25, 2021

Kent Imaging Becomes Net Health’s First Integrated Imaging Device

By David Godkin, Staff Writer TORONTO – Think of it. More than 14,000 facilities boasting 98% of the largest hospital chains across the U.S., two-thirds of skilled nursing facilities and hospice …
January 19, 2021

TVM Life Science Innovation II SCSp Announces Investment in ImmunoRx Pharma, Inc.

Luxembourg, January 19th, 2021 –TVM Life Science Innovation II SCSp today announced the fund’s investment establishing ImmunoRx Pharma, Inc., a company based in Wilmington, Delaware. ImmunoRx Pha…
January 13, 2021

Kent Imaging Inc. is accelerating its growth through a US$15M investment by TVM Life Science Innovation II SCSp

CALGARY, AB, CANADA, January 13, 2021 /EINPresswire.com/ — Kent Imaging, an innovator in the tissue imaging market, announced today its partnership with TVM Life Science Innovation II SCS…
November 13, 2020

Dentsply Sirona and Panthera Dental announce collaboration: fully digital workflow for custom-made sleep devices

(Charlotte/Quebec, November 12, 2020) Dentists now have the opportunity to use Primescan in a new area of application: Obstructive Sleep Apnea (OSA) and snoring, which affects up to 3.61 billion p…
October 27, 2020

TVM Capital Life Science Announces Substantially Oversubscribed US$478 Million Final Closing of TVM Life Science Innovation II, largest fund in the firm’s history

The Fund continues the proven “Project Focused Company” investment strategy for early-stage drug development candidates. In addition, the Fund continues to invest in late-stage clinical biopharmac…